Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey.

Heart and vessels - 1 Jul 2004

Ayyildiz Orhan, Kalkanli Sevgi, Batun Sabri, Aybak Mehmet, Isikdogan Abdurrahman, Tiftik Naci, Bolaman Zahit, Soker Murat, Muftuoglu Ekrem

Abstract excerpt

Venous thrombosis (VT) is a common disease, with an annual incidence in the general population of approximately 1 per 1000. The prevalence of genetic risk factors for thrombosis varies greatly in different parts of the world. Prothrombin G20210A (PT G20210A) gene mutation has been recently identified as a common risk factor in venous thrombosis. Sixty-one patients with VT, differing in age and sex, and 340...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Point Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymerase Chain Reaction

Share to Prevalence

Share to Prothrombin

Share to Risk Factors

Share to Turkey

Share to Venous Thrombosis

Source

Identifiers

PMID: 15278388
DOI: 10.1007/s00380-003-0760-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey.PMID 15278388Read ↗

Detection of Factor V Leiden and prothrombin c.20210G>A allele by Roche Diagnostics LightCycler®.Semantic proximity Read ↗

Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosisSemantic proximity Read ↗

Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis.Semantic proximity Read ↗

Frequency of genetic mutations associated with thromboembolism in the Western Black Sea Region.Semantic proximity Read ↗

The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.Semantic proximity Read ↗

Prevalence of factor V Leiden and prothrombin G20210A gene mutation.Semantic proximity Read ↗

Whole blood samples for faster real-time PCR analysis of thrombophilic mutations in SARS-CoV-2 virus positive patients.Semantic proximity Read ↗

Combined factor V leiden (G1691A) and prothrombin (G20210A) genotyping by multiplex real-time polymerase chain reaction using fluorescent resonance energy transfer hybridization probes on the Rotor-Gene 2000.Semantic proximity Read ↗

Prevalence of genetic prothrombotic risk factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population.Semantic proximity Read ↗

Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3'-untranslated region of the prothrombin gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.